(Q39117932)

9 September 2017

title

Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification (English)

1 reference

9 September 2017

1 reference

R Noro

1

1 reference

9 September 2017

K Honda

2

1 reference

9 September 2017

K Tsuta

3

1 reference

9 September 2017

G Ishii

4

1 reference

9 September 2017

A M Maeshima

5

1 reference

9 September 2017

N Miura

6

1 reference

9 September 2017

K Furuta

7

1 reference

9 September 2017

T Shibata

8

1 reference

9 September 2017

H Tsuda

9

1 reference

9 September 2017

A Ochiai

10

1 reference

9 September 2017

T Sakuma

11

1 reference

9 September 2017

N Nishijima

12

1 reference

9 September 2017

A Gemma

13

1 reference

9 September 2017

H Asamura

14

1 reference

9 September 2017

K Nagai

15

1 reference

9 September 2017

T Yamada

16

1 reference

9 September 2017

publication date

30 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

24

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

2594-2600

1 reference

Screening for lung cancer: a review of the current literature.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Overview of observational studies of low-dose helical computed tomography screening for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

E-cadherin regulates the association between beta-catenin and actinin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Neuroblastoma: biological insights into a clinical enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Survival after surgery in stage IA and IB non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT293

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT293

1 reference

9 September 2017

1 reference